Penumbra (PEN)
(Delayed Data from NYSE)
$234.36 USD
+12.21 (5.50%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $234.45 +0.09 (0.04%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 21% (54 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.57 | 9.99 |
Current Quarter Estimate | 0.42 | 3.93 | 59.00 |
Year Ago Quarter Estimate | 0.23 | 3.85 | 50.37 |
Next Quarter Estimate | 0.61 | 3.92 | 60.00 |
Next Year Estimate | 3.97 | 19.76 | 238.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 36.36 | 11.60 | 20.73 |
Next Year | 39.30 | 23.10 | 13.55 |
Last 5 Years | 32.80 | 8.50 | 9.00 |
Next 5 Years | 35.60 | 14.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 106.29 | 29.13 |
Price/Book (MRQ) | 7.27 | 2.46 |
Price/Cash Flow (MRFY) | 78.56 | 14.55 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 8.59% | -8.85% |
Return on Equity (TTM) | 7.49% | -7.83% |
Debt to Equity (MRQ) | 0.02 | 17.89 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.